Skip to content

Enhanced self-care for advanced lymphoedema

Enhanced self-care protocol for severe case management of lymphoedema

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN16764792
Enrollment
640
Registered
2018-04-04
Start date
2018-10-08
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower limb lymphoedema caused by either

Interventions

19 districts in Bangladesh and 20 districts in Ethiopia have information on burden of disease. In each country, 20 health facility catchments are randomly selected using a random number generator. Of
1. Daily washing and drying of the limbs 2. Attending to entry lesions to prevent secondary bacterial infections 3. Daily elevation and simple exercises

Sponsors

Liverpool School of Tropical Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients lymphoedema, their carers and community health workers who: 1. Reside within a 10 km radius of the selected health facilities 2. Are 18 years of age or older 3. Patients must have moderate to severe leg lymphoedema as defined as stage 3 or above according to the Dreyer staging system for filarial lymphoedema 4. Patients must be able to perform the daily self-care protocol either independently or with the aid of a carer. 5. Carers must be available on a daily basis to assist the patient with lymphoedema-care activities as needed 6. All participants must be able to provide informed consent

Exclusion criteria

Exclusion criteria: Patients lymphoedema, their carers and community health workers who: 1. Are under 18 years of age 2. Decline to be involved in the study 3. Are unable to give informed consent 4. Are too unwell to participate 5. Lymphoedema patients who have mild leg lymphoedema as defined as stage 2 or below according to the Dreyer staging system for filarial lymphoedema 6. Patients with any medical condition eg heart, kidney, lung disease 7. Patients with severe arthritis 8. Patients with traumatic injury or surgery on the lymphoedema limb 9. Patients or carers who are unable or unwilling to perform daily lymphoedema-care activities

Design outcomes

Primary

MeasureTime frame
Lymphoedema status is measured at baseline prior to participants receiving the training in lymphoedema care, and after 4, 12 and 24 weeks of performing the daily protocol using: 1. Lymphoedema stage according to the Dreyer 7 stage system 2. Limb circumference at mid-calf using a tape measure 3. Subcutaneous tissue compressibility at mid-calf using an indurometer (the Indurometer is a small hand held device which non-invasively measures the degree of tissue compressibility in the skin and subcutaneous compartment. This device is previously validated in women with breast cancer-related arm lymphoedema and young, asymptomatic people residing in an LF endemic region in Myanmar)

Secondary

MeasureTime frame
1. Adherence to the self-care protocol measured at baseline prior to participants receiving the training in lymphoedema care, and after 4, 12 and 24 weeks of performing the daily protocol using: 1.1. Daily journal kept by the participant and collected at each follow-up measure 1.2. Knowledge, attitudes and practices (KAP) questionnaire administered at baseline and after 24 weeks 2. Self-reported symptoms measured at baseline prior to participants receiving the training in lymphoedema care, and after 4, 12 and 24 weeks of performing the daily protocol using: 2.1. Pain 2.2. Perceived level of functional disability 2.3. Frequency and duration of acute attacks (secondary bacterial infections) 2.4. Days of work lost due to the disease 3. Quality of life measured using visual analogue scale at baseline prior to participants receiving the training in lymphoedema care, and after 4, 12 and 24 weeks of performing the daily protocol

Countries

Bangladesh, Ethiopia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026